Linden Thomson, lead manager of the Axa IM Framlington Biotech fund, tells Natalie Kenway that after extremely low investor sentiment towards the sector at the start of 2022, the fundamentals for biotech investing have greatly improved.
Fund in Five: Royal London Global Sustainable Equity Fund
In this fund in five, George Crowdy, co-manager of the Royal London Sustainable Equity fund, discusses the wider investment universe the portfolio can invest in.
The Launch Pad: Eric Papesh, T Rowe Price US Structured Research Equity fund
In the third of the new series, Adam Lewis talks to Eric Papesh, US equity specialist at T Rowe Price
Interview with Fiona Harris
Fiona Harris, investment specialist on the JP Morgan American Investment Trust, discusses the drivers of performance over the last year and where the fund is currently finding the best investment opportunities.
Interview with Christopher Rossbach, J. Stern & Co
Christopher Rossbach, manager of the J. Stern & Co World Stars Global Equity fund, discusses his outlook, fund positioning, and what investing for the long term genuinely means.
Fund in Five: Artemis SmartGARP® Global Emerging Markets Equity Fund
In this Fund in Five we talk to Raheel Altaf, lead manager of the Artemis SmartGARP® Global Emerging Markets Equity Fund, to look at the portfolio from five angles.
Interview with Brad Weafer
Truly focused, truly active. Brad Weafer, Chief Investment Officer at Boston Financial Management, lays out the key characteristics of the Marlborough US Multi-Cap Income Fund.
Introducing CCLA – pioneers in responsible investing
Get to know CCLA Investment Management in this short video. CCLA has a long heritage in sustainable investment, having pioneered ethical and responsible investing since 1958.